RYLAZE
RYLAZE
Approved
DIN Number
02530406
Drug Class
Human
Market Date
May 3, 2023
Company
HC
JAZZ PHARMACEUTICALS IRELAND LIMITED
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02530406
AIG Number0164041001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L01XX02 ASPARAGINASE
Product Specifications
Dosage FormSolution
Route of AdministrationIntramuscular
AHFS Classification44:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
CRISANTASPASEActive
Strength: 10 MG / 0.5 ML
Monograph: CRISANTASPASE